Safety of medical treatments for endometriosis

Research output: Contribution to journalArticle

Abstract

Introduction: All medical treatments for endometriosis are equally effective in relieving pain. However, all of them alleviate pain symptoms for as long as they are used, but pain always relapses when medication is discontinued. Therefore, medications need to be used in the long term.Areas covered: Formulations of estro-progestins that contain less than 50 μg of estrogen are associated with a low risk of venous thrombosis, myocardial infarction and stroke. When considering the neoplastic effects, data suggest that the overall risk of invasive cancer by age 60 is not increased in previous users of hormonal contraceptives. The use of progestins for contraception has never been associated with an increased risk of breast cancer, venous thromboembolism or bone fractures. Although more data on long-term therapy with progestins are needed, treatment of endometriosis with progestins may be feasible in women with metabolic or cardiovascular contraindications to estroprogestin. The other medications for the treatment of pain associated with endometriosis are less appropriate for long term administration because of side effects (danazol and GnRH analogues), costs (aromatase inhibitors and GnRH agonists) or necessity of complex regimens of associations (GnRH agonists and add back therapy or aromatase inhibitors plus progestins).Expert opinion: Progestins and estroprogestins are safe drugs to use in the long term. Adherence to these medications may be high because, being a contraceptive, they are perceived less as a medication for the treatment of a disease. The annual cost of therapy compares favorably with other available medications. Progestins and estroprogestins represent the first-line medications for the treatment of endometriosis associated pain.

Original languageEnglish
Pages (from-to)21-30
Number of pages10
JournalExpert Opinion on Drug Safety
Volume15
Issue number1
DOIs
Publication statusPublished - Jan 2 2016

Fingerprint

Endometriosis
Progestins
Safety
Pain
Gonadotropin-Releasing Hormone
Aromatase Inhibitors
Therapeutics
Contraceptive Agents
Danazol
Costs and Cost Analysis
Medication Adherence
Bone Fractures
Venous Thromboembolism
Expert Testimony
Contraception
Venous Thrombosis
Estrogens
Stroke
Myocardial Infarction
Breast Neoplasms

Keywords

  • chronic pelvic pain
  • hormonal treatment of endometriosis
  • oral contraceptives

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

@article{60ced6e073014dc7a40e8ceae9128d93,
title = "Safety of medical treatments for endometriosis",
abstract = "Introduction: All medical treatments for endometriosis are equally effective in relieving pain. However, all of them alleviate pain symptoms for as long as they are used, but pain always relapses when medication is discontinued. Therefore, medications need to be used in the long term.Areas covered: Formulations of estro-progestins that contain less than 50 μg of estrogen are associated with a low risk of venous thrombosis, myocardial infarction and stroke. When considering the neoplastic effects, data suggest that the overall risk of invasive cancer by age 60 is not increased in previous users of hormonal contraceptives. The use of progestins for contraception has never been associated with an increased risk of breast cancer, venous thromboembolism or bone fractures. Although more data on long-term therapy with progestins are needed, treatment of endometriosis with progestins may be feasible in women with metabolic or cardiovascular contraindications to estroprogestin. The other medications for the treatment of pain associated with endometriosis are less appropriate for long term administration because of side effects (danazol and GnRH analogues), costs (aromatase inhibitors and GnRH agonists) or necessity of complex regimens of associations (GnRH agonists and add back therapy or aromatase inhibitors plus progestins).Expert opinion: Progestins and estroprogestins are safe drugs to use in the long term. Adherence to these medications may be high because, being a contraceptive, they are perceived less as a medication for the treatment of a disease. The annual cost of therapy compares favorably with other available medications. Progestins and estroprogestins represent the first-line medications for the treatment of endometriosis associated pain.",
keywords = "chronic pelvic pain, hormonal treatment of endometriosis, oral contraceptives",
author = "Nicola Berlanda and Edgardo Somigliana and Paola Vigan{\`o} and Vercellini, {Paolo Pietro}",
year = "2016",
month = "1",
day = "2",
doi = "10.1517/14740338.2016.1121991",
language = "English",
volume = "15",
pages = "21--30",
journal = "Expert Opinion on Drug Safety",
issn = "1474-0338",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Safety of medical treatments for endometriosis

AU - Berlanda, Nicola

AU - Somigliana, Edgardo

AU - Viganò, Paola

AU - Vercellini, Paolo Pietro

PY - 2016/1/2

Y1 - 2016/1/2

N2 - Introduction: All medical treatments for endometriosis are equally effective in relieving pain. However, all of them alleviate pain symptoms for as long as they are used, but pain always relapses when medication is discontinued. Therefore, medications need to be used in the long term.Areas covered: Formulations of estro-progestins that contain less than 50 μg of estrogen are associated with a low risk of venous thrombosis, myocardial infarction and stroke. When considering the neoplastic effects, data suggest that the overall risk of invasive cancer by age 60 is not increased in previous users of hormonal contraceptives. The use of progestins for contraception has never been associated with an increased risk of breast cancer, venous thromboembolism or bone fractures. Although more data on long-term therapy with progestins are needed, treatment of endometriosis with progestins may be feasible in women with metabolic or cardiovascular contraindications to estroprogestin. The other medications for the treatment of pain associated with endometriosis are less appropriate for long term administration because of side effects (danazol and GnRH analogues), costs (aromatase inhibitors and GnRH agonists) or necessity of complex regimens of associations (GnRH agonists and add back therapy or aromatase inhibitors plus progestins).Expert opinion: Progestins and estroprogestins are safe drugs to use in the long term. Adherence to these medications may be high because, being a contraceptive, they are perceived less as a medication for the treatment of a disease. The annual cost of therapy compares favorably with other available medications. Progestins and estroprogestins represent the first-line medications for the treatment of endometriosis associated pain.

AB - Introduction: All medical treatments for endometriosis are equally effective in relieving pain. However, all of them alleviate pain symptoms for as long as they are used, but pain always relapses when medication is discontinued. Therefore, medications need to be used in the long term.Areas covered: Formulations of estro-progestins that contain less than 50 μg of estrogen are associated with a low risk of venous thrombosis, myocardial infarction and stroke. When considering the neoplastic effects, data suggest that the overall risk of invasive cancer by age 60 is not increased in previous users of hormonal contraceptives. The use of progestins for contraception has never been associated with an increased risk of breast cancer, venous thromboembolism or bone fractures. Although more data on long-term therapy with progestins are needed, treatment of endometriosis with progestins may be feasible in women with metabolic or cardiovascular contraindications to estroprogestin. The other medications for the treatment of pain associated with endometriosis are less appropriate for long term administration because of side effects (danazol and GnRH analogues), costs (aromatase inhibitors and GnRH agonists) or necessity of complex regimens of associations (GnRH agonists and add back therapy or aromatase inhibitors plus progestins).Expert opinion: Progestins and estroprogestins are safe drugs to use in the long term. Adherence to these medications may be high because, being a contraceptive, they are perceived less as a medication for the treatment of a disease. The annual cost of therapy compares favorably with other available medications. Progestins and estroprogestins represent the first-line medications for the treatment of endometriosis associated pain.

KW - chronic pelvic pain

KW - hormonal treatment of endometriosis

KW - oral contraceptives

UR - http://www.scopus.com/inward/record.url?scp=84955189212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955189212&partnerID=8YFLogxK

U2 - 10.1517/14740338.2016.1121991

DO - 10.1517/14740338.2016.1121991

M3 - Article

VL - 15

SP - 21

EP - 30

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

SN - 1474-0338

IS - 1

ER -